Self-Regulated Magnetic Hyperthermia Using Curie-Temperature Tunable Nanomaterials: Development of Ni-Cu and La₁₋ₓAgₓMnO₃ Nanoalloys with Biocompatible Coatings for Cancer Therapy

Abstract

Background: Magnetic hyperthermia represents a promising therapeutic modality for cancer treatment, yet precise temperature control remains a critical challenge in clinical applications. Self-regulating nanomaterials with Curie temperatures (TC) within the therapeutic window (39-46°C) offer potential solutions for preventing thermal damage to healthy tissues while maximizing tumor cell destruction.

Objective: This study aimed to develop and comprehensively characterize novel nanomaterials with self-regulated heating capabilities for magnetic hyperthermia applications, focusing on Ni-Cu nanoalloys and La₁₋ₓAgₓMnO₃ perovskite nanoparticles with biocompatible surface modifications.

Methods: Nanoparticles were synthesized using both conventional and microwave-enhanced heating methods, with hydrazine and ammonium chloride as activating agents. Materials were coated with zinc phosphate (Zn₃(PO₄)₂) and carbon shells to enhance biocompatibility. Physical characterization included magnetic property analysis, particle size distribution, morphology assessment, and uniformity evaluation. Toxicity profiles were established using multi-branch maze and open-field behavioral assays in Wistar rats (n=120, 60 per treatment group), with control groups maintained under standard laboratory conditions. In vitro heating efficiency was evaluated in simulated physiological environments under alternating magnetic fields (frequency: 100-400 kHz, amplitude: 5-15 kA/m).

Results: Synthesized Ni-Cu nanoalloys demonstrated TC values ranging from 40.2±1.3°C to 44.8±1.1°C (p<0.05 between compositions), with particle sizes of 18-35 nm. La₁₋ₓAgₓMnO₃ nanoparticles exhibited TC values of 39.7±0.9°C to 45.3±1.2°C, with mean particle diameter of 22-42 nm. Microwave synthesis reduced production time by 73% compared to conventional methods while improving particle uniformity (coefficient of variation: 12.3% vs. 19.8%, p<0.001). Zn₃(PO₄)₂-coated materials showed superior biocompatibility, with behavioral toxicity scores 2.4-fold lower than uncoated particles (p<0.001). Under magnetic hyperthermia conditions (43±0.5°C for 30 minutes), learning retention in the multi-branch maze test decreased by only 8.3±2.1% compared to controls (p=0.042), indicating minimal neurotoxic effects. Open-field locomotor activity remained within 92% of baseline values. Specific absorption rate (SAR) values reached 87-156 W/g for optimized formulations, with temperature self-regulation demonstrated through TC-limited heating curves.

Conclusions: The developed Ni-Cu and La₁₋ₓAgₓMnO₃ nanomaterials with biocompatible coatings demonstrate excellent self-regulating properties, high heating efficiency, and acceptable toxicity profiles. The materials' intrinsic temperature control via Curie point transition provides a safety mechanism against overheating, addressing a major limitation in current magnetic hyperthermia protocols. These findings support advancement to preclinical in vivo tumor models and eventual clinical translation.

Clinical Implications: Self-regulating magnetic nanoparticles may reduce complications associated with conventional hyperthermia treatments, potentially enabling safer outpatient procedures with minimized monitoring requirements. The material's predictable temperature ceiling could facilitate standardization of treatment protocols across different clinical settings.